Has William Williams, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,366 in general payments to William Williams, MD across 226 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Williams, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Williams, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Williams, MD

Interventional Pain Medicine · Johnson City, TNNPI 1952396236

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Medtronic at 49.9% of the total. Reporting peaked in 2019 at $1,177 and has fallen 76.9% since, to $272 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in TN, where the typical reported total is $5,250.

$4,366in general payments, 2019–2025

Across 226 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
Nevro Corp.$741
Collegium Pharmaceutical, Inc.$389
Abbott$355
Stimwave Technologies Incorporated$157
Boston Scientific$142
plus $403 from 14 others

What the payments were for

Food & beverage$4,366100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	132	$2,180
Nevro Corp.	26	$741
Collegium Pharmaceutical, Inc.	17	$389
Abbott	17	$355
Stimwave Technologies Incorporated	4	$157
Boston Scientific	4	$142
Scilex Pharmaceuticals Inc.	3	$46
GRT US Holding, Inc.	1	$44
Globus Medical	2	$39
Pacira Therapeutics, Inc.	3	$36
Takeda Pharmaceuticals U.S.A., Inc.	3	$36
Tersera Therapeutics LLC	2	$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$34
Assertio Therapeutics, Inc.	2	$29
Zyla Life Sciences, Inc.	2	$23
Biodelivery Sciences International, Inc.	2	$23
Nalu Medical, Inc.	1	$17
Redhill Biopharma Inc.	1	$15
Amneal Pharmaceuticals LLC	1	$14
MDD US Operations, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,366 in reported general payments places this provider in the 45th percentile of 41 interventional pain medicine providers in Tennessee.

See all interventional pain medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024

$52,506

Medicare patients

145

Services billed

2,560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	35	$1,048
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	48	$986
Tramadol Hcl	88	$820
Gabapentin	69	$743
Morphine Sulfate ErMorphine Sulfate	20	$621
Oxycodone Hcl	20	$371
Duloxetine Hcl	23	$320
Tizanidine Hcl	16	$273
Cyclobenzaprine Hcl	11	$200
Zolpidem Tartrate	15	$148
Methocarbamol	11	$124
Acetaminophen-CodeineAcetaminophen With Codeine	11	$94
Methadone Hcl	11	$61
Cephalexin	12	$39

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Johnson City

Michael WilkinsonJohnson City$35K
Cameron ShawverJohnson City$15K
Sameh WardJohnson City$6K
William NewtonWinchester$225K
Ryan BearerWinchester$35K
Jacob MillsMountain Home$24K
Matthew KangasMemphis$22K
Matthew RupertFranklin$17K
Adolfo CuadraKnoxville$15K
Christine LeslieMorristown$12K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →